Archives

Category Archive for: ‘Contraceptives’

Yaz Update from Bayer stockholder’s newsletter

The third quarter Bayer stockholder’s newsletter provided the following update about the YAZ®, YASMIN®, Ocella™ and Gianvi® liability litigation ongoing in the U.S.: As of October 15, 2012, the number of lawsuits pending in the United States and served upon Bayer was about 12,400. In addition, about 720 asserted claims were pending that have not been filed in court. The …

Read More

Bayer settles some Yasmin lawsuits for $402 million

Bayer AG, maker of Yasmin birth control pills, has paid more than $402 million to settle nearly 1,900 lawsuits in the U.S., the company told stockholders. Bayer also reported that it has doubled its reserve to $610.5 million to settle future cases. The settled lawsuits were filed over claims that Yasmin and Yaz contraceptives caused clots that could lead to …

Read More

FDA wants blood clotting data added to Yaz, Yasmin, others

Based on a recently completed safety review, the FDA has concluded that birth control pills containing drospirenone (a synthetic version of the female hormone progesterone, also known as progestin) may be associated with a higher risk for blood clots than other progestin-containing pills. The FDA is adding information about the studies to the labels of drospirenone-containing birth control pills such …

Read More

Pfizer Recalls 1M Packets of Birth Control Pills

As the result of a packaging error, Pfizer has recalled 1M packets of birth control pills.  A statement issued by Pfizer indicated that, “As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception and at risk for unintended pregnancy.  The recall involves 14 lots of Lo/Ovral-28 …

Read More

BREAKING NEWS- YAZ Settlement Discussions to Begin

January 5, 2012.  The first Yaz trial which was set to begin next week has been postponed in an effort to reach a settlement of the claims. Judge David Herndon has appointed a mediator to work with the parties to reach a settlement. There have been more than 10,000 suites filed in the Multidistrict Litigation.

Read More

FDA Panel: Newer birth control medications should carry stronger safety warnings.

NBC Nightly News (12/8, story 7, 2:20, Williams) reported, “Medical experts have been taking…[a] look at Drospirenone/Ethinyl Estradiol [Yaz], because of studies that show they may be more likely to cause dangerous blood clots than older versions of the” medication. Chief Medical Editor Dr. Nancy Snyderman said, “Two of the most popular birth control” medications “in use — Yaz and …

Read More

FDA Questions Safety of newer birth control drugs

Research suggesting that the newer birth control formulations are more likely to cause blood clots that the older drugs has prompted the Food and Drug Administration to consider new safety measures. Yaz, Yasmin and other pills containing a synthetic hormone called drospirenone as well as the Ortho Evra patch which uses the hormone norelgestromin are the focus of the discussion. …

Read More